In contrast, a significant number of CD45+ cells were in the tumor of the RaST-treated group compared to the untreated control (Fig. 5d), with a sizable number in the periphery (p-value 0.0077) than the core (p-value 0.0461) of the tumor (Fig. 5e). This evidence concerns the gene PTPRC and neoplasm.